2332 Stock Overview
Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Zhejiang Xianju Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.48 |
| 52 Week High | CN¥15.80 |
| 52 Week Low | CN¥8.44 |
| Beta | -0.27 |
| 1 Month Change | 25.19% |
| 3 Month Change | 9.02% |
| 1 Year Change | -22.48% |
| 3 Year Change | -21.32% |
| 5 Year Change | 51.45% |
| Change since IPO | 28.96% |
Recent News & Updates
Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Apr 15
There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding
Mar 05Shareholder Returns
| 2332 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 10.0% | 0.8% | -0.4% |
| 1Y | -22.5% | -13.4% | -14.4% |
Return vs Industry: 002332 underperformed the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 002332 underperformed the CN Market which returned -14.4% over the past year.
Price Volatility
| 2332 volatility | |
|---|---|
| 2332 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 002332 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002332's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | 3,336 | Weihua Jin | www.xjpharma.com |
Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products.
Zhejiang Xianju Pharmaceutical Co.,Ltd. Fundamentals Summary
| 2332 fundamental statistics | |
|---|---|
| Market cap | CN¥11.36b |
| Earnings (TTM) | CN¥691.79m |
| Revenue (TTM) | CN¥4.16b |
16.4x
P/E Ratio2.7x
P/S RatioIs 2332 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2332 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.16b |
| Cost of Revenue | CN¥1.97b |
| Gross Profit | CN¥2.19b |
| Other Expenses | CN¥1.50b |
| Earnings | CN¥691.79m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.70 |
| Gross Margin | 52.61% |
| Net Profit Margin | 16.61% |
| Debt/Equity Ratio | 4.6% |
How did 2332 perform over the long term?
See historical performance and comparison